Clinical and Translational Radiation Oncology

Slides:

Advertisements

Similar presentations

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.

Advertisements

A retrospective outcomes review of patients with idiopathic normal pressure hydrocephalus treated with a low flow valve system Phillip G. St. Louis, MD,

Neoadjuvant twice daily chemoradiotherapy for esophageal cancer: Treatment-related mortality and long-term outcomes Stuart E. Samuels, MD, PhD, Matthew.

Expression Levels of KMT2C and SLC20A1 Identified by Information-theoretical Analysis Are Powerful Prognostic Biomarkers in Estrogen Receptor-positive.

miR p Is a Novel Prognostic Biomarker of Prostate Cancer

Relationship between high normal TSH levels and metabolic syndrome components in type 2 diabetic subjects with euthyroidism Lilit Petrosyan Journal.

A Clinical Prognostic Index for Patients Treated with Erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21 Marie Florescu,

Incidence and clinical impact of chemotherapy induced myelotoxicity in cancer patients: An observational retrospective survey Lazzaro Repetto Critical.

Rituximab, fludarabine, and cyclophosphamide versus fludarabine and cyclophosphamide for treatment of chronic lymphocytic leukemia: A systematic review.

Managing Cancer Pain: Basic Principles and Invasive Treatments

Critical Reviews in Oncology / Hematology

Independent validation of the prognostic value of cancer stem cell marker expression and hypoxia-induced gene expression for patients with locally advanced.

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Alzheimer's disease drug development pipeline: 2018

Local control and overall survival after frameless radiosurgery: A single center experience Angelika Bilger, Florian Frenzel, Oliver Oehlke, Rolf Wiehle,

The immediate effect of musculoskeletal physiotherapy techniques and massage on pain and ease of breathing in adults with cystic fibrosis Annemarie Lee,

Clinical and Translational Radiation Oncology

Clinical and Translational Radiation Oncology

Physics and Imaging in Radiation Oncology

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Volume 148, Issue 1, Pages (January 2018)

Pain in cancer survivors; filling in the gaps

Vulvar intraepithelial neoplasia: Risk factors for recurrence

Physics and Imaging in Radiation Oncology

A Clinical Prognostic Index for Patients Treated with Erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21 Marie Florescu,

Patient-reported symptoms and performance status before palliative radiotherapy in geriatric cancer patients (octogenarians) Carsten Nieder, Thomas A.

Surgery vs. primary radiotherapy in early-stage oropharyngeal cancer

Role of radiotherapy in extracranial metastatic malignant melanoma in the modern era Ryan S. Youland, Miran L. Blanchard, Roxanna Dronca, Lisa Kottschade,

Clinical and Translational Radiation Oncology

M. Ulm, D. Lee, A.R. Mabe, M.P. Lowe, S. Kumar, T. Tillmanns

Leukocytosis, prognosis biomarker in locally advanced head and neck cancer patients after chemoradiotherapy Antoine Schernberg, Pierre Blanchard, Cyrus.

PARADIGM-2: Two parallel phase I studies of olaparib and radiotherapy or olaparib and radiotherapy plus temozolomide in patients with newly diagnosed.

Jojanneke M. Seinen, Maarten G

Clinical and Translational Radiation Oncology

K. Bixel, N. Denlinger, L. Marsh, A. Quick, R. Salani

Volume 152, Issue 1, Pages (January 2019)

Follow up results of a prospective study to evaluate the impact of FDG-PET on CT- based radiotherapy treatment planning for oesophageal cancer Sweet Ping.

Comparing the health and economic impacts of cervical cancer screening strategies using the Cancer Risk Management Model (CRMM) C. Popadiuk, A.J. Coldman,

Radiomic analysis in prediction of Human Papilloma Virus status

Survivors' acceptance of treatment side effects evolves as goals of care change over the cancer continuum A. Ellis, M.K. Frey, L.M. Koontz, S. Shyne,

Evaluating the prevalence and predictive factors of vasomotor and psychological symptoms in prostate cancer patients receiving hormonal therapy: Results.

Susan C. Miller, PhD, Dan K. Kiely, MPH, MA, Joan M

Concurrent chemotherapy and intensity modulated radiation therapy in the treatment of anal cancer: A retrospective review from a large academic center

Impact of waiting time on nodal staging in head and neck squamous-cell carcinoma treated with radical intensity modulated radiotherapy Cédric Chevalier,

Study of diffusion weighted MRI as a predictive biomarker of response during radiotherapy for high and intermediate risk squamous cell cancer of the oropharynx:

Jean-Emmanuel Bibault, Ingeborg Tinhofer

FORECAST – A cloud-based personalized intelligent virtual coaching platform for the well-being of cancer patients Sofoklis Kyriazakos, Vincenzo Valentini,

What is the impact of diabetes mellitus on radiation induced acute proctitis after radical radiotherapy for adenocarcinoma prostate? A prospective longitudinal.

Influence of rifaximin treatment on the susceptibility of intestinal Gram-negative flora and enterococci H.L. DuPont, Z.-D. Jiang Clinical Microbiology.

Prognostic impact of leukocyte counts before and during radiotherapy for oropharyngeal cancer Garrett L. Jensen, Pierre Blanchard, G. Brandon Gunn, Adam.

Prognostic and Predictive Role of the VeriStrat Plasma Test in Patients with Advanced Non–Small-Cell Lung Cancer Treated with Erlotinib or Placebo in.

Differences in patterns of care and outcomes between grade II and grade III molecularly defined 1p19q co-deleted gliomas Debra Nana Yeboa, James B. Yu,

Telehealth in radiation oncology at the Townsville Cancer Centre: Service evaluation and patient satisfaction Elizabeth Hamilton, Ellie Van Veldhuizen,

Rectal volume variations and estimated rectal dose during 8 weeks of image-guided radical 3D conformal external beam radiotherapy for prostate cancer

Shorter duration of antibiotic treatment for acute bacteraemic cholangitis with successful biliary drainage: a retrospective cohort study A. Doi, T.

Plasma proteins as prognostic biomarkers in radiotherapy treated head and neck cancer patients Line Brøndum, Jesper Grau Eriksen, Brita Singers Sørensen,

Association between Systemic Chemotherapy before Chemoradiation and Increased Risk of Treatment-Related Pneumonitis in Esophageal Cancer Patients Treated.

News & Notes Journal of Allergy and Clinical Immunology

Aisling Krishnan, Yat Man Tsang, Adéle Stewart-Lord

Patterns of practice in palliative radiotherapy for bleeding tumours in the Netherlands; a survey study among radiation oncologists Jennifer Strijbos,

Analysis of pseudoprogression after proton or photon therapy of 99 patients with low grade and anaplastic glioma Julianna K. Bronk, Nandita Guha-Thakurta,

Effect of neuraxial anaesthesia on tumour progression in cervical cancer patients treated with brachytherapy: a retrospective cohort study H Ismail,

Managing Cancer Pain: Basic Principles and Invasive Treatments

Volume 2, Issue 6, Pages (June 2017)

Volume 115, Issue 1, Pages (October 2009)

Clinical and Translational Radiation Oncology

Clinical and Translational Radiation Oncology

Effect of Tumor Size on Prognosis in Patients Treated with Radical Radiotherapy or Chemoradiotherapy for Non–Small Cell Lung Cancer: An Analysis of the.

Volume 154, Issue 1, Pages (July 2019)

Systematic review of methodology used in clinical studies evaluating the benefits of proton beam therapy Mercy Ofuya, Lucy McParland, Louise Murray,

Presentation transcript:

Clinical and Translational Radiation Oncology Anemia, leukocytosis and thrombocytosis as prognostic factors in patients with cervical cancer treated with radical chemoradiotherapy: A retrospective cohort study Theodora A. Koulis, Elizabeth N. Kornaga, Robyn Banerjee, Tien Phan, Prafull Ghatage, Anthony M. Magliocco, Susan P. Lees-Miller, Corinne M. Doll Clinical and Translational Radiation Oncology Volume 4, Pages 51-56 (June 2017) DOI: 10.1016/j.ctro.2017.05.001 Copyright © 2017 The Authors Terms and Conditions

Fig. 1 5-year PFS (A) and OS (B) for patients with Hgb levels >115g/L (high Hgb) vs patients with both anemia and leukocytosis. Clinical and Translational Radiation Oncology 2017 4, 51-56DOI: (10.1016/j.ctro.2017.05.001) Copyright © 2017 The Authors Terms and Conditions

Fig. 2 5-year PFS (A) and OS (B) for patients with Hgb levels >115g/L (high Hgb) vs patients with both anemia and elevated NLR. Clinical and Translational Radiation Oncology 2017 4, 51-56DOI: (10.1016/j.ctro.2017.05.001) Copyright © 2017 The Authors Terms and Conditions

Fig. 3 5-year PFS (A) and OS (B) comparing patient’s Hgb status throughout treatments: Hgb levels >115g/L both pre- and during-treatment (HH group), normal pre-treatment and low during treatment (HL group), low pre-treatment and normal during treatment (LH group), and low both pre- and during-treatment (LL group). Clinical and Translational Radiation Oncology 2017 4, 51-56DOI: (10.1016/j.ctro.2017.05.001) Copyright © 2017 The Authors Terms and Conditions